Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR. [PDF]
Esfandiari F+9 more
europepmc +1 more source
In Vivo Evidence on the Emerging Potential of Non-Digestible Oligosaccharides as Therapeutic Agents in Bacterial and Viral Infections. [PDF]
Afsharnia A+6 more
europepmc +1 more source
A Review of Recent Progress in the Mechanisms and Effectiveness of Acupuncture for Treating Allergic Rhinitis. [PDF]
Bu F, Lou Z.
europepmc +1 more source
Mechanisms of microbe-mediated immune development in the context of antibiotics and asthma. [PDF]
Donald K, Finlay BB.
europepmc +1 more source
Genome assembly of a potential probiotic Bifidobacterium bifidum BB11 strain isolated from Holstein calves. [PDF]
Langa S, Mamphogoro TP.
europepmc +1 more source
Effects of probiotic supplementation on intestinal flora, brain-gut peptides and clinical outcomes in children with anorexia nervosa. [PDF]
Lu X, Liu Y, Hao L, Li J, Hua L.
europepmc +1 more source
Related searches:
Bifidobacteria can protect from enteropathogenic infection through production of acetate
Nature, 2011Shinji Fukuda, Koji Hase, Tohru Suzuki
exaly +2 more sources
Lactoferrin and bifidobacteria
BioMetals, 2014We herein summarized the effects of lactoferrin (LF) on bifidobacteria. Many in vitro studies previously reported the growth-promoting (bifidogenic) effects of LF on bifidobacteria. The involvement of bound iron, sugar chains, and LF peptides has been proposed in this bifidogenic mechanism.
Hiroyuki Wakabayashi+3 more
openaire +2 more sources
breast fed infants. These organisms are also found in the human adult intestine, vagina, and mouth, and in the alimentary tract of various kinds of animals. In the past much confusion existed regarding the taxonomy of the bifidobacteria, partly because of the incomplete methods .
Tomotari Mitsuoka, Choji Kaneuchi
openaire +3 more sources
INTRODUCTION The low FODMAP diet (LFD) reduces symptoms and bifidobacteria in irritable bowel syndrome (IBS). β-galactooligosaccharides (B-GOS) may reduce the symptoms and increase bifidobacteria in IBS.
B. Wilson+8 more
semanticscholar +1 more source